Astellas Pharma Inc (OTCPK:ALPMY)
$ 9.72 -0.18 (-1.82%) Market Cap: 17.43 Bil Enterprise Value: 21.25 Bil PE Ratio: 0 PB Ratio: 1.80 GF Score: 77/100

Astellas Pharma Inc Sustainability Meeting Transcript

Feb 21, 2024 / 01:00AM GMT
Release Date Price: $11.12 (-0.18%)
Hiromitsu Ikeda
Astellas Pharma Inc. - Corporate Head of Advocacy & Relations

Thank you very much for joining Sustainability Meeting 2023 by Astellas out of your very busy schedule.

I am Ikeda, Chief Communications and IR Officer. Very nice to meet you.

Today's session, including the Q&A session, will be held with simultaneous interpretation in Japanese and English. We cannot guarantee the accuracy of interpretation. Thank you for your understanding.

You can set the language from the menu on the Zoom webinar screen. If you choose original, you can listen the original audio without simultaneous interpretation.

Today's presentation material is posted on our website. This material or our presentation by representatives of the company and answers and statements by representatives of the company in the Q&A session includes forward-looking statements based on assumptions and beliefs in light of the information currently available to management and subject to significant risks and uncertainties.

Actual financial results may differ materially depending

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot